This study evaluates the pattern of urinary N-acetyl-f3-D-glucosaminidase (NAG) isoenzyme excretion in patients with spinal cord injury (SCI) and its use as a diagnostic tool in localising the site of urinary tract infection (UTI). NAG-B excretion in 27 control SCI patients (mean 207·78 units) was significantly higher than in 10 normal controls (mean 12·6 units) p<O·OOl). The relative isoenzyme distribution as represented by NAG-BITotal NAG percentage is however similar in both groups, 24·27 and 20·38% respectively. NAG-B excretion in 6 SCI patients with upper UTI was not significantly higher than in 12 SCI patients with lower UTI. NAG-BITotal NAG percentage was significantly different between these two groups (35·3% and 24·98% respectively, p<0·05). There was no significant difference in NAG-B excretion or NAG-BITotal NAG percentage between control SCI patients and those with lower UTI. The results indicate that there is a non-selective increase in urinary NAG excretion in control SCI patients and those with lower UTI. In SCI patients with upper urinary UTI there is a selective increase in NAG-B excretion. The overlap in enzyme values between the different groups suggests that the test may not be clinically useful in localising the site of UTI.
criteria for the diagnosis of UTI are not applicable in these patients due to the frequent occurrence of asymptomatic bacteruria (Gribble et al., 1988) .
The use of urinary enzyme excretion in the localisation of UTI has been studied in other patient populations (Vigano et al., 1983; Sandberg et al., 1986; Mengoli et al., 1982; Carrajal et al., 1975; Devaskar and Montgomery, 1978) . The most promising of the enzymes tested is N-acetyl-�-D glucosaminidase (NAG) a lysosomal enzyme of 70 000 molecular weight present in A and B isoenzyme forms (Tucker et al., 1980) . The normal adult excretes predominantly NAG-A in the urine (Hultberg et al., 1974) . However clinical situations where renal tubular injury occur have been associated with elevation of Total NAG (Alderman et al., 1983; Johnston et ai., 1983; Kind, 1982) and preferential elevation of NAG-B excretion (Severini et al., 1988; Poon et al., 1979) . The proximal renal tubular cells are rich in NAG-B and injury to these cells is thought to result in release of this isoenzyme in the urine.
The aim of our investigation was to study the pattern of NAG isoenzyme excretion in the urine of SCI patients and to evaluate its usefulness as a clinical test in the localisation of UTI.
Subjects and Methods
Forty five SCI patients (44 males and 1 female) were admitted to our Rehabilitation Centre for long term rehabilitation, 34 healthy control subjects were also included in this study. The controls were classified into two groups (I, II) and the patients into three group (III, IV, V). The groups and criteria for inclusion are given below while the clinical profile of the patient groups is given in Table II. Group I: Normal healthy controls (No. 10) Criteria: A normal male subject having no· dysuria or fever and no clinical evidence of systemic disease with a normal urine microscopy.
Group II : Normal controls with non-urinary tract sources of fever (No. 24) Criteria: A male subject without evidence of any systemic illness having a fever of less than 1 week duration, > 10 1· 5°F on the day of collection of the sample, no symptoms of UTI, a normal urine culture or a normal urine microscopy and a normal serum creatinine. Initial urine cultures in Group III were all significantly positive. Hence urine culture was not routinely obtained in the remaining subjects. Urine for enzyme estimation was collected in clean bottles from indwelling Foley's catheters using aseptic precautions or by sterile intermittent catheterisation depending on the voiding method used by the patient.
Urine samples were routinely spun at 400xg for 10 minutes and dialysed against 50 volumes ofO'IM Tris-HCl buffer pH 7' 1 for 16 hours at 4°C with two changes of buffer. Dialysed urine samples were assayed either immediately or stored at -20°C and assayed within 7 days for enzyme. NAG was assayed spectrophoto metrically at 400 nm using p-nitrophenyl-N-acetyl-glucosaminide as substrate (Basu et al., 1977) . The assay system consisted of 100 mmol citrate phosphate buffer pH 4'5, 100 Ilg bovine serum albumin, 1 mmol substrate and enzyme upto 140 III in a total volume of 200 Ill. Incubation was carried out at 37°C for 60 minutes and the reaction stopped by the addition of 800 III 0'4M glycine-NaOH pH 10'5.
The differential assay of NAG-B was carried out by heat inactivation of NAG-A at 50°C for 180 minutes of 140 III enzyme in 100 mmol citrate-phosphate buffer pH 4'5 and 100 Ilg bovine serum albumin. This was followed by the addition of 1 mmol substrate and incubation and termination of the reaction as given above.
Creatinine was estimated by the Jaffe reaction (Brod and Sirota, 1948) . Enzyme units are expressed as 11 moles p-nitrophenol released/hour/mg creatinine.
Statistical analysis
The NAG-B excretion rate and NAG-B/Total NAG percentage between the individual groups were compared by the Mann-Whitney U test. The NAG-B/Total NAG percentage is used as a measure of the relative isoenzyme distribution. The effect of individual clinical variables on NAG-B enzymuria (Table II) could not be statistically analysed due to the small number of subjects in the individual subgroups.
Results
The mean and range of NAG-B excretion and NAG-B/Total NAG percentage in Groups I to V are given in Table I .
No statistically significant difference in NAG-B excretion was observed between
Group I and II indicating that fever alone did not cause NAG-B enzymuria. There were no significant differences in NAG-B excretion between Group III and IV and in NAG-B/Total NAG percentage between Groups I and III, III and IV. The differences in NAG-B excretion between Groups IV and V and NAG-B/Total NAG percentage between Groups III and V do not reach the level of significance (p=O·0608 and p=O·0531 respectively).
There were statistically significant differences in NAG-B excretion between Group I and III (p<O·OOl), Group II and III (p<O·OOI), Group III and V (p<O·Ol) and in NAG-B/Total NAG percentage between Group IV and V (p<O·05). In upper UTI in SCI patients there appears to be a preferential increase in NAG B enzymuria which maybe indicative of specific renal tubular damage occurring in this situation (Watts et ai., 1988) . This observation should be interpreted in light of the lack of suitable gold standards to diagnose and localise UTI in SCI patients and the small sample size of SCI patients with upper UTI (Group V) in this study.
The effect of individual clinical variables such as the level and duration of SCI and the method of bladder drainage on NAG-B enzymuria could not be analysed due to the small size of the individual subgroups (Table II) Although there is a difference in NAG-B enzymuria between SCI patients with upper and lower UTI, this does not reach a level of significance. Moreover, the 
